The aim of this study was to test whether perioperative treatment with rosuvastatin 20 mg could prevent the incidence of postoperative atrial fibrillation and reduce myocardial damage in patients undergoing cardiac surgery. The data showed that rosuvastatin was not effective in preventing the occurrence of atrial fibrillation or reduce myocardial damage measured by troponin.
1_barbara_casadei
Barbara Casadei
2014-09-02
Original title: Statin Therapy in Cardiac Surgery. STICS.
